Company news
Polynovo Limited (ASX:PNV) news
Polynovo Limited news releases on 6ix. Latest, Jan 7, 2020: Two Million Dollar Month
Press releases — page 3
Two Million Dollar Month
January 7, 2020
BTM CE mark approval
December 13, 2019
AGM 2019 Chairman, CEO & SVP Sales Address
November 15, 2019
S&P DJI Announces September 2019 Quarterly Rebalance
September 5, 2019
Annual Report Brokers Presentation
August 22, 2019
Annual Report FY19 and 4E
August 21, 2019
Singapore Regulatory Approval
August 8, 2019
Progress Report
May 31, 2019
Million Dollar Month
May 2, 2019
US Dept of Defence & access to other Federal contracts
May 1, 2019
Half Yearly Report and Accounts
February 21, 2019
PolyNovo Purchases additional production facility
January 18, 2019
Malaysia Regulatory Approval
January 17, 2019
H1 Sales FY19 PolyNovo
January 7, 2019
PolyNovo Sales FY19 YTD Market Update
November 28, 2018
AGM Chairman and CEO Address to Shareholders
November 16, 2018
NovoSorb BTM aaproved for sale in India
November 1, 2018
S&P DJI Announces September 2018 Quarterly Rebalance
September 6, 2018
Annual Report to Shareholders and Appendix 4E
August 16, 2018
Final Patient enrolled in BARDA Feasibility Burn Trial
August 2, 2018
NovoSorb BTM approved for sale in Saudi Arabia
July 26, 2018
Final patient enrolled in CE Mark Burn Trial
May 22, 2018
PolyNovo Announces Breast Device Development Program
April 3, 2018
Results announcement, App 4D and Half-Year Financial Report
February 15, 2018
PolyNovo Announces Breast Device Development Agreement
January 17, 2018
PolyNovo signs MOU for global breast partnership
October 15, 2017
New Sales and Repeat Orders in the US
October 11, 2017
PolyNovos Israel Market Entry
October 4, 2017
Placement and Share Purchase Plan
September 24, 2017
Further US Sales for NovoSorb BTM
September 14, 2017
First US Sales of BTM Novosorb
September 1, 2017
Annual Report to shareholders and Appendix 4E
August 24, 2017
Business update and earnings guidance
May 19, 2017
Research project collaboration with Beta Cell Technologies
May 11, 2017
Additional Success US BTM use
February 26, 2017
First BTM patient in US
February 22, 2017
South Africa first order for BTM
February 16, 2017
First stock purchase
December 21, 2016
PolyNovos South Africa Market Entry
December 8, 2016
S&P DJ Indices Announces March Quarterly Review
November 7, 2016
US Market Entry-PolyNovo
October 2, 2016
Full Year Statutory Accounts and Appendix 4E
August 22, 2016
Financial result guidance
August 7, 2016
BTM use in Diabetes Islet Cell Transplantation Study
July 24, 2016
Additional BARDA Option Exercised Valued at US$2.4m
May 31, 2016
US Regulatory Update
March 30, 2016
Financial Result Guidance
February 11, 2016
US FDA approval
February 10, 2016